I appreciate your take on things. My point, and maybe it didn't come across clearly, was that the "surgically-sized" articulated arm technology may have its own limits in terms of what it is capable of doing within constraints of physical size, surgical environment, materials, production cost, maintenance, etc.. We are not in science fiction land like the Martian probes going through the basement in War of the Worlds, yet.
This company has done some impressive engineering. Their smallest arm is much, much larger than what is in SPORT.
The SPORT arms and controllers will need to perform well in the real world of doing surgery with small instruments. They will need to be improved upon as weaknesses are identified (and they will be). Haptics will add a whole new level of complexity. The training and skill to use them is anyone's guess, outside of Titan/Ximedica.
So, while you can attest to the perceptions of surgeons, I attest to the perceptions of engineers. If Titan will be a game-changer as we hope, heavy development of the arm technology and its IP will play a big part in any success.
News 
Market Data 
Discover 
